BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20457620)

  • 1. IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.
    Ning Y; Riggins RB; Mulla JE; Chung H; Zwart A; Clarke R
    Mol Cancer Ther; 2010 May; 9(5):1274-85. PubMed ID: 20457620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.
    Nehra R; Riggins RB; Shajahan AN; Zwart A; Crawford AC; Clarke R
    FASEB J; 2010 Jun; 24(6):2040-55. PubMed ID: 20154269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.
    Crawford AC; Riggins RB; Shajahan AN; Zwart A; Clarke R
    PLoS One; 2010 Jan; 5(1):e8604. PubMed ID: 20062536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.
    Riggins RB; Zwart A; Nehra R; Clarke R
    Mol Cancer Ther; 2005 Jan; 4(1):33-41. PubMed ID: 15657351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.
    Cook KL; Wärri A; Soto-Pantoja DR; Clarke PA; Cruz MI; Zwart A; Clarke R
    Clin Cancer Res; 2014 Jun; 20(12):3222-32. PubMed ID: 24928945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
    Bouker KB; Skaar TC; Fernandez DR; O'Brien KA; Riggins RB; Cao D; Clarke R
    Cancer Res; 2004 Jun; 64(11):4030-9. PubMed ID: 15173018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of estrogen receptor-α induces autophagy and inhibits antiestrogen-mediated unfolded protein response activation, promoting ROS-induced breast cancer cell death.
    Cook KL; Clarke PA; Parmar J; Hu R; Schwartz-Roberts JL; Abu-Asab M; Wärri A; Baumann WT; Clarke R
    FASEB J; 2014 Sep; 28(9):3891-905. PubMed ID: 24858277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.
    Clarke R; Shajahan AN; Riggins RB; Cho Y; Crawford A; Xuan J; Wang Y; Zwart A; Nehra R; Liu MC
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):8-20. PubMed ID: 19444933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
    Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
    J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.
    Fulda S; Debatin KM
    Oncogene; 2002 Apr; 21(15):2295-308. PubMed ID: 11948413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways.
    Suk K; Chang I; Kim YH; Kim S; Kim JY; Kim H; Lee MS
    J Biol Chem; 2001 Apr; 276(16):13153-9. PubMed ID: 11278357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells.
    Smolnikar K; Löffek S; Schulz T; Michna H; Diel P
    Breast Cancer Res Treat; 2000 Oct; 63(3):249-59. PubMed ID: 11110059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative contributions of interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells.
    Horiuchi M; Itoh A; Pleasure D; Ozato K; Itoh T
    J Neuroinflammation; 2011 Jan; 8():8. PubMed ID: 21261980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
    Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC
    J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.
    Rao X; Di Leva G; Li M; Fang F; Devlin C; Hartman-Frey C; Burow ME; Ivan M; Croce CM; Nephew KP
    Oncogene; 2011 Mar; 30(9):1082-97. PubMed ID: 21057537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.
    Long X; Fan M; Bigsby RM; Nephew KP
    Mol Cancer Ther; 2008 Jul; 7(7):2096-108. PubMed ID: 18645020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIGHT/IFN-γ triggers β cells apoptosis via NF-κB/Bcl2-dependent mitochondrial pathway.
    Zheng QY; Cao ZH; Hu XB; Li GQ; Dong SF; Xu GL; Zhang KQ
    J Cell Mol Med; 2016 Oct; 20(10):1861-71. PubMed ID: 27241100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.